Goldman Sachs’s IGC Pharma IGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.1K | Hold |
65,541
| – | – | ﹤0.01% | 5048 |
|
|
2025
Q1 | $18.7K | Hold |
65,541
| – | – | ﹤0.01% | 4977 |
|
|
2024
Q4 | $22K | Hold |
65,541
| – | – | ﹤0.01% | 4902 |
|
|
2024
Q3 | $28K | Buy |
65,541
+46
| +0.1% | +$20 | ﹤0.01% | 4693 |
|
|
2024
Q2 | $28.4K | Hold |
65,495
| – | – | ﹤0.01% | 4593 |
|
|
2024
Q1 | $26.2K | Hold |
65,495
| – | – | ﹤0.01% | 4583 |
|
|
2023
Q4 | $18.3K | Sell |
65,495
-1
| -0% | – | ﹤0.01% | 4613 |
|
|
2023
Q3 | $23.5K | Sell |
65,496
-17
| -0% | -$6 | ﹤0.01% | 4546 |
|
|
2023
Q2 | $20.4K | Buy |
65,513
+10
| +0% | +$3 | ﹤0.01% | 4753 |
|
|
2023
Q1 | $22.2K | Buy |
65,503
+10
| +0% | +$3 | ﹤0.01% | 4868 |
|
|
2022
Q4 | $20.8K | Sell |
65,493
-8
| -0% | -$3 | ﹤0.01% | 4888 |
|
|
2022
Q3 | $28K | Buy |
65,501
+7
| +0% | +$3 | ﹤0.01% | 5108 |
|
|
2022
Q2 | $35K | Buy |
65,494
+11
| +0% | +$6 | ﹤0.01% | 5344 |
|
|
2022
Q1 | $62K | Sell |
65,483
-1,148
| -2% | -$1.09K | ﹤0.01% | 5424 |
|
|
2021
Q4 | $65K | Hold |
66,631
| – | – | ﹤0.01% | 5307 |
|
|
2021
Q3 | $99K | Sell |
66,631
-16,629
| -20% | -$24.7K | ﹤0.01% | 5053 |
|
|
2021
Q2 | $137K | Hold |
83,260
| – | – | ﹤0.01% | 5042 |
|
|
2021
Q1 | $149K | Hold |
83,260
| – | – | ﹤0.01% | 4939 |
|
|
2020
Q4 | $130K | Buy |
83,260
+16,980
| +26% | +$26.5K | ﹤0.01% | 4417 |
|
|
2020
Q3 | $69K | Sell |
66,280
-200
| -0.3% | -$208 | ﹤0.01% | 4283 |
|
|
2020
Q2 | $40K | Buy |
66,480
+200
| +0.3% | +$120 | ﹤0.01% | 4266 |
|
|
2020
Q1 | $32K | Hold |
66,280
| – | – | ﹤0.01% | 4318 |
|
|
2019
Q4 | $42K | Sell |
66,280
-1
| -0% | -$1 | ﹤0.01% | 4211 |
|
|
2019
Q3 | $64K | Buy |
66,281
+28,901
| +77% | +$27.9K | ﹤0.01% | 4101 |
|
|
2019
Q2 | $61K | Hold |
37,380
| – | – | ﹤0.01% | 4073 |
|
|
2019
Q1 | $78K | Buy |
+37,380
| New | +$78K | ﹤0.01% | 4040 |
|
|
2014
Q3 | – | Sell |
-10,437
| Closed | -$15K | – | 4543 |
|
|
2014
Q2 | $15K | Buy |
+10,437
| New | +$15K | ﹤0.01% | 4364 |
|